Theravance Biopharma (TBPH) Interest Expenses (2016 - 2025)
Theravance Biopharma (TBPH) reported Interest Expenses of $582,000 for Q4 2025, down 9.5% from $643,000 a year earlier but up 1.6% from the prior quarter.
Powered by 
Analysis
Theravance Biopharma (TBPH) Interest Expenses (2016 - 2025) Analysis & Trends
For FY2025, Theravance Biopharma posted Interest Expenses of $2.46 million, down 3.3% from FY2024.
- Interest Expenses has a five-year compound annual growth rate of -22.0% (FY2020 to FY2025).
- By year, Interest Expenses came in at $2.55 million in FY2024 (+8.3%), $2.35 million in FY2023 (-63.1%), $6.37 million in FY2022 (-25.5%) and $8.55 million in FY2021 (unchanged).
- Five-year quarterly Interest Expenses spans a low of $550,000 in Q4 2022 and a high of $11.87 million in Q1 2021.
- Year over year, Interest Expenses gained in six of the last eight quarters, with growth averaging 2.6%.
- The high point for year-over-year Interest Expenses in five years was Q1 2021 (growth of 19.4%); the low point was Q1 2022 (a decline of 82.0%).
- Per Business Quant data, the three quarters before Q4 2025 came in at $573,000 (Q3 2025), $663,000 (Q2 2025) and $643,000 (Q1 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int Expense (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 281.00 Mn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | - |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | - |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | -462.00 Mn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | -435.00 Mn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 673.00 Mn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 247.00 Mn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | - |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | - |
| 10 | Theravance Biopharma | 883.70 Mn | -543.66 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | 582,000.00 |
| Sep 30, 2025 | 573,000.00 |
| Jun 30, 2025 | 663,000.00 |
| Mar 31, 2025 | 643,000.00 |
| Dec 31, 2024 | 643,000.00 |
| Sep 30, 2024 | 630,000.00 |
| Jun 30, 2024 | 644,000.00 |
| Mar 31, 2024 | 629,000.00 |
| Dec 31, 2023 | 623,000.00 |
| Sep 30, 2023 | 609,000.00 |
| Jun 30, 2023 | 568,000.00 |
| Mar 31, 2023 | 550,000.00 |
| Dec 31, 2022 | 550,000.00 |
| Sep 30, 2022 | 1.55 Mn |
| Jun 30, 2022 | 2.14 Mn |
| Mar 31, 2022 | 2.14 Mn |
| Dec 31, 2021 | 2.14 Mn |
| Sep 30, 2021 | 2.14 Mn |
| Jun 30, 2021 | 11.61 Mn |
| Mar 31, 2021 | 11.87 Mn |
API Access
Theravance Biopharma Interest Expenses API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=interest-expenses&ticker=TBPH&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "interest-expenses", "ticker": "TBPH", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=interest-expenses&ticker=TBPH&period=max&api_key=YOUR_API_KEY");
const data = await res.json();